A Novel CRISPR Interference Effector Enabling Functional Gene Characterization with Synthetic Guide RNAs.


Journal

The CRISPR journal
ISSN: 2573-1602
Titre abrégé: CRISPR J
Pays: United States
ID NLM: 101738191

Informations de publication

Date de publication:
Dec 2022
Historique:
pubmed: 19 10 2022
medline: 16 12 2022
entrez: 18 10 2022
Statut: ppublish

Résumé

While CRISPR interference (CRISPRi) systems have been widely implemented in pooled lentiviral screening, there has been limited use with synthetic guide RNAs for the complex phenotypic readouts enabled by experiments in arrayed format. Here we describe a novel deactivated Cas9 fusion protein, dCas9-SALL1-SDS3, which produces greater target gene repression than first or second generation CRISPRi systems when used with chemically modified synthetic single guide RNAs (sgRNAs), while exhibiting high target specificity. We show that dCas9-SALL1-SDS3 interacts with key members of the histone deacetylase and Swi-independent three complexes, which are the endogenous functional effectors of SALL1 and SDS3. Synthetic sgRNAs can also be used with

Identifiants

pubmed: 36257604
doi: 10.1089/crispr.2022.0056
pmc: PMC9805873
doi:

Substances chimiques

CRISPR-Associated Protein 9 EC 3.1.-
RNA, Guide, CRISPR-Cas Systems 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

769-786

Références

Science. 2014 Jan 3;343(6166):84-87
pubmed: 24336571
Mol Cell Biol. 2004 Mar;24(6):2364-72
pubmed: 14993276
Nat Methods. 2015 Dec;12(12):1143-9
pubmed: 26501517
Cell Res. 2013 Oct;23(10):1163-71
pubmed: 23979020
Genome Res. 2020 Jan;30(1):22-34
pubmed: 31804951
Nat Rev Genet. 2008 Jul;9(7):554-66
pubmed: 18521077
Mol Pharm. 2018 Mar 5;15(3):759-767
pubmed: 29384380
Nucleic Acids Res. 1996 Dec 15;24(24):4859-67
pubmed: 9016654
Proc Natl Acad Sci U S A. 2008 Dec 23;105(51):20380-5
pubmed: 19091943
PLoS One. 2016 Dec 28;11(12):e0168968
pubmed: 28030641
Nat Methods. 2018 Aug;15(8):611-616
pubmed: 30013045
Nucleic Acids Res. 2018 Jul 6;46(12):5950-5966
pubmed: 29860520
J Biotechnol. 2015 Oct 10;211:56-65
pubmed: 26189696
Proc Natl Acad Sci U S A. 1996 Dec 24;93(26):15299-304
pubmed: 8986806
PLoS One. 2009;4(4):e5120
pubmed: 19357772
Proc Natl Acad Sci U S A. 2020 Mar 24;117(12):6571-6579
pubmed: 32156728
Nat Methods. 2015 Apr;12(4):326-8
pubmed: 25730490
J Exp Med. 2018 Mar 5;215(3):985-997
pubmed: 29436394
Cell. 2021 Apr 1;184(7):1790-1803.e17
pubmed: 33735607
Genes Dev. 1996 Aug 15;10(16):2067-78
pubmed: 8769649
Nature. 2004 Mar 25;428(6981):431-7
pubmed: 15042092
Mol Cell Biol. 2006 Nov;26(22):8623-38
pubmed: 16954381
Cell Res. 2012 Aug;22(8):1227-45
pubmed: 22613949
Mol Cell Biol. 2002 Apr;22(8):2743-50
pubmed: 11909966
Nature. 2015 Jan 29;517(7536):583-8
pubmed: 25494202
J Biotechnol. 2020 Aug 10;319:25-35
pubmed: 32470463
Commun Biol. 2021 May 12;4(1):568
pubmed: 33980985
Nat Biotechnol. 2016 Jun;34(6):631-3
pubmed: 27111720
Nat Commun. 2013;4:2203
pubmed: 23892279
Proc Natl Acad Sci U S A. 2015 Jun 30;112(26):E3384-91
pubmed: 26080438
Cell Rep. 2016 Oct 25;17(5):1438-1452
pubmed: 27783955
Assay Drug Dev Technol. 2010 Apr;8(2):186-99
pubmed: 20085456
Mol Cell. 2009 Jul 31;35(2):228-39
pubmed: 19647519
Nature. 2001 May 24;411(6836):494-8
pubmed: 11373684
Genome Res. 2021 Nov;31(11):2120-2130
pubmed: 34407984
Nat Protoc. 2013 Nov;8(11):2180-96
pubmed: 24136345
Sci Rep. 2020 Jan 20;10(1):635
pubmed: 31959800
Cell. 2004 Jun 11;117(6):721-33
pubmed: 15186774
Mol Hum Reprod. 2014 Jul;20(7):650-63
pubmed: 24674991
Biomedicines. 2022 Jan 04;10(1):
pubmed: 35052782
Nat Methods. 2009 Jun;6(6):443-5
pubmed: 19448642
Nat Biotechnol. 2000 May;18(5):538-43
pubmed: 10802622
Cell. 1997 May 2;89(3):357-64
pubmed: 9150135
J Biol Chem. 2006 Aug 18;281(33):23922-31
pubmed: 16707490
Nat Methods. 2020 Nov;17(11):1093-1096
pubmed: 33020655
Genes Dev. 2001 Feb 15;15(4):428-43
pubmed: 11230151
EMBO J. 2017 Aug 1;36(15):2216-2232
pubmed: 28554894
Cell. 2018 Jun 28;174(1):231-244.e12
pubmed: 29804834
Nature. 2007 Apr 12;446(7137):815-9
pubmed: 17429401
Genome Biol. 2010;11(10):R106
pubmed: 20979621
Genome Res. 2014 Jan;24(1):125-31
pubmed: 24253447
Nat Biotechnol. 2013 Mar;31(3):230-2
pubmed: 23360966
Pharmacol Res. 2021 Feb;164:105304
pubmed: 33202255
Science. 2022 Feb 4;375(6580):eabj4008
pubmed: 35113687
Elife. 2016 Sep 23;5:
pubmed: 27661255
Cell. 2021 Apr 29;184(9):2503-2519.e17
pubmed: 33838111
Neuron. 2019 Oct 23;104(2):239-255.e12
pubmed: 31422865
Nucleic Acids Res. 2017 Sep 29;45(17):9901-9916
pubmed: 28973434
Mol Cell Proteomics. 2018 Jul;17(7):1432-1447
pubmed: 29599190
Cell. 2013 Jul 18;154(2):442-51
pubmed: 23849981
Genome Biol. 2021 Jan 26;22(1):47
pubmed: 33499898
Cell. 2020 Dec 23;183(7):2020-2035.e16
pubmed: 33326746
Mol Cell Biol. 1998 Sep;18(9):5121-7
pubmed: 9710596
Biochim Biophys Acta. 2006 Mar;1762(3):386-91
pubmed: 16443351
Science. 2014 Jan 3;343(6166):80-4
pubmed: 24336569
Cell. 1997 May 2;89(3):341-7
pubmed: 9150133
Mol Syst Biol. 2014 Oct 30;10:757
pubmed: 25358341
SLAS Discov. 2021 Dec;26(10):1337-1354
pubmed: 34218704
Methods Mol Med. 2003;76:449-65
pubmed: 12526179
Mol Ther. 2000 Jul;2(1):47-55
pubmed: 10899827
Cell. 1997 May 2;89(3):349-56
pubmed: 9150134
Cell. 2014 Oct 23;159(3):647-61
pubmed: 25307932
Methods Mol Biol. 2012;852:51-9
pubmed: 22328425
PLoS Genet. 2010 Mar 05;6(3):e1000869
pubmed: 20221260
Science. 2013 Feb 15;339(6121):823-6
pubmed: 23287722
PLoS One. 2014 Dec 26;9(12):e115987
pubmed: 25541967
Nat Cell Biol. 2020 Sep;22(9):1143-1154
pubmed: 32884147
Science. 2013 Feb 15;339(6121):819-23
pubmed: 23287718
PLoS One. 2017 Nov 27;12(11):e0188593
pubmed: 29176845
Elife. 2013 Jan 29;2:e00471
pubmed: 23386978
Science. 2017 Jan 6;355(6320):
pubmed: 27980086

Auteurs

Clarence Mills (C)

Horizon Discovery, a PerkinElmer Company, Lafayette, Colorado, USA and University of Colorado-Boulder, Boulder, Colorado, USA.

Andrew Riching (A)

Horizon Discovery, a PerkinElmer Company, Lafayette, Colorado, USA and University of Colorado-Boulder, Boulder, Colorado, USA.

Ashleigh Keller (A)

Horizon Discovery, a PerkinElmer Company, Lafayette, Colorado, USA and University of Colorado-Boulder, Boulder, Colorado, USA.

Jesse Stombaugh (J)

Horizon Discovery, a PerkinElmer Company, Lafayette, Colorado, USA and University of Colorado-Boulder, Boulder, Colorado, USA.

Amanda Haupt (A)

Horizon Discovery, a PerkinElmer Company, Lafayette, Colorado, USA and University of Colorado-Boulder, Boulder, Colorado, USA.

Elena Maksimova (E)

Horizon Discovery, a PerkinElmer Company, Lafayette, Colorado, USA and University of Colorado-Boulder, Boulder, Colorado, USA.

Sarah M Dickerson (SM)

Horizon Discovery, a PerkinElmer Company, Lafayette, Colorado, USA and University of Colorado-Boulder, Boulder, Colorado, USA.

Emily Anderson (E)

Horizon Discovery, a PerkinElmer Company, Lafayette, Colorado, USA and University of Colorado-Boulder, Boulder, Colorado, USA.

Kevin Hemphill (K)

Horizon Discovery, a PerkinElmer Company, Lafayette, Colorado, USA and University of Colorado-Boulder, Boulder, Colorado, USA.

Chris Ebmeier (C)

Mass Spectrometry Core Facility, University of Colorado-Boulder, Boulder, Colorado, USA.

John A Schiel (JA)

Horizon Discovery, a PerkinElmer Company, Lafayette, Colorado, USA and University of Colorado-Boulder, Boulder, Colorado, USA.

Josien Levenga (J)

Horizon Discovery, a PerkinElmer Company, Lafayette, Colorado, USA and University of Colorado-Boulder, Boulder, Colorado, USA.

Matthew Perkett (M)

Horizon Discovery, a PerkinElmer Company, Lafayette, Colorado, USA and University of Colorado-Boulder, Boulder, Colorado, USA.

Anja van Brabant Smith (AVB)

Horizon Discovery, a PerkinElmer Company, Lafayette, Colorado, USA and University of Colorado-Boulder, Boulder, Colorado, USA.

Zaklina Strezoska (Z)

Horizon Discovery, a PerkinElmer Company, Lafayette, Colorado, USA and University of Colorado-Boulder, Boulder, Colorado, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH